Citations

Showing 10 of 108152 citations.

Human chorionic gonadotropin suspected heterophile interference investigations in immunoassays: a recommended approach
Jara-Aguirre, Jose C., Baumann, N, Block, Darci R , Baumann, Nikola A, Algeciras‐Schimnich, Alicia

Mayo Clinic

Clinical Chemistry and Laboratory Medicine (CCLM) | July 6, 2019 | Volume: 57 | Issue: 8 | Pages: 1192-1196

10.1515/cclm-2018-1142 | PMID 30753153 Get It

Abstract Background Heterophile antibody (HAb) interferences in immunoassays can cause falsely elevated hCG concentrations leading to incorrect diagnosis and treatments options. When results are not consistent with the clinical findings, hCG HAb interference investigation may be requested by the physician. A retrospective evaluation of the frequency of HAb interference was performed among cases of physician-requested investigations and the effectiveness of commercially available blocking reagents to detect HAb interference in two immunoassay systems was evaluated. Methods One hundred and thirteen physician requests for hCG HAb investigation from 2008 to 2017 were reviewed. The primary method used to measure hCG was the Beckman Coulter Access Total βhCG (2008–2010) and the Roche Elecsys HCG+β (2014–2017). HAb investigation included measurement by two immunoassays before and after treatment of samples with heterophile blocking reagents and serial dilution studies. Results Five cases of HAb and HAb-like interference were identified. The interference frequency was 6.7% for the Beckman assay and 2.9% for the Roche assay. The presence of HAb was detected using heterophile blocking reagents and an alternative method in three cases. The other two cases were detected due to discrepant results with an alternative method and non-linear serial dilutions (HAb-like). Conclusions HAb interference was observed in the Beckman and the Roche assays. The heterophile blocking reagents failed to detect 40% of interference cases. Blocking reagents should not solely be used for these investigations. Multiple strategies including the use of serial dilutions and using an alternative platform are critical when troubleshooting interferences in hCG immunoassays.
Molecular Genetics in the Diagnosis and Biology of Lymphoid Neoplasms
Lim, Megan S. , Bailey, Nathanael G. , King, Rebecca L. , Piris, Miguel Á. , Piris, Miguel , Lim, Megan S

Mayo Clinic

American Journal of Clinical Pathology | July 6, 2019 | Volume: 152 | Issue: 3 | Pages: 277-301

10.1093/ajcp/aqz078 | PMID 31278738 Get It

AbstractObjectivesThe 2017 Workshop of the Society for Hematopathology/European Association for Haematopathology reviewed the role of molecular genetics in the diagnosis and biology of lymphoid neoplasms.MethodsThe Workshop Panel reviewed 82 cases.ResultsMolecular genetic testing reveals alterations that expand the spectrum of diseases such as DUSP22 rearrangement in ALK-negative anaplastic large cell lymphoma, large B-cell lymphoma with IRF4 rearrangement, MYD88 mutations in B-cell lymphomas, Burkitt-like lymphoma with 11q aberrations, and diagnostic criteria for high-grade B-cell lymphomas. Therapeutic agents and natural tumor progression may be associated with transcriptional reprogramming that lead to transdifferentiation and lineage switch.ConclusionsApplication of emerging technical advances has revealed the complexity of genetic events in lymphomagenesis, progression, and acquired resistance to therapies. They also contribute to enhanced understanding of the biology of indolent vs aggressive behavior, clonal evolution, tumor progression, and transcriptional reprogramming associated with transdifferentiation events that may occur subsequent to therapy.
Acute Pulmonary Embolism: Contemporary Approach to Diagnosis, Risk-Stratification, and Management
Tak, Tahir , Karturi, Swetha, Eckstein, Lee H, Poterucha, Joseph T., Sandoval, Yader , Eckstein, Lee, Sharma, Umesh

Mayo Clinic

International Journal of Angiology | July 5, 2019 | Volume: 28 | Issue: 02 | Pages: 100-111

10.1055/s-0039-1692636 | PMID 31384107 Get It

AbstractPulmonary embolism (PE) affects over 300,000 individuals each year in the United States and is associated with substantial morbidity and mortality. Improvements in the diagnostic performance and availability of computed tomographic pulmonary angiography and D-dimer testing have facilitated the evaluation of patients with suspected PE. High clinical suspicion is required in those with risk factors and/or those that manifest signs or symptoms of venous thromboembolic disease, with validated clinical risk scores such as the Wells and modified Wells score or the PE rule-out criteria helpful in estimating the likelihood for PE. For those with confirmed PE, patients should be categorized and triaged according to the presence or absence of shock or hypotension. Normotensive patients can be further risk-stratified using validated prognostic risk scores, as well as by using imaging and cardiac biomarkers, with those having either signs of right ventricular dysfunction on imaging studies and/or abnormal cardiac biomarkers categorized as being at intermediate-risk and requiring close monitoring and hospital admission. Early discharge and/or home therapy are possible in those that do not manifest any high-risk features. The initial treatment for most patients that are stable consists of anticoagulation, with advanced therapies such as thrombolysis, catheter-based therapies, or surgical embolectomy deferred for those at high risk. Given the heterogeneous presentations of PE and various management strategies available, the development of multidisciplinary PE response teams has emerged to help facilitate decision-making in these patients.
Glomerular Volume and Glomerulosclerosis at Different Depths within the Human Kidney
Đenić, Aleksandar , Ricaurte, Luisa , Lopez, Camden , Narasimhan, Ramya , Lerman, Lilach O. , Thompson, R. Houston, Kremers, Walter K. , Rule, Andrew D. , Rule, Andrew D , Denic, Aleksandar , Lopez, Camden L , Kremers, Walter K , Lieske, John C.

Mayo Clinic

Journal of the American Society of Nephrology | July 5, 2019 | Volume: 30 | Issue: 8 | Pages: 1471-1480

10.1681/asn.2019020183 | PMID 31278193 Get It

Significance Statement Research investigating glomerular morphology in different cortical regions has been limited to animal models and a small number of human autopsy kidneys. In this study, the authors used tissue from living patients who underwent a radical nephrectomy (for a renal tumor) to characterize glomerular morphology and glomerulosclerosis by cortical depth. They found that glomerular volume and glomerulosclerosis differed by depth across three cortical regions (superficial, middle, and deep). Although most clinical associations with glomerulosclerosis and glomerulomegaly did not differ by cortical depth, there were important exceptions. Age-related glomerulosclerosis appeared to be an ischemic process and was more evident in the superficial (subcapsular) region. Diabetes-related glomerulosclerosis was more evident in the deep (juxtamedullary) region. Obesity more strongly associated with larger glomeruli in the superficial region. Background Age, CKD risk factors, and kidney function are associated with larger glomerular volume and a higher percentage of globally sclerotic glomeruli. Knowledge of how these associations may differ by cortical depth is limited. Methods To investigate glomerular volume and glomerulosclerosis across different depths of cortex, we studied wedge sections of the renal parenchyma from 812 patients who underwent a radical nephrectomy (for a tumor), separately characterizing glomeruli in the superficial (subcapsular), middle, and deep (juxtamedullary) regions. We compared the association of mean nonsclerotic glomerular volume and of glomerulosclerosis (measured as the percentage of globally sclerotic glomeruli) with age, obesity, diabetes, smoking, kidney function, and structural pathology in the superficial, middle, and deep regions. Results The superficial, middle, and deep regions showed significant differences in glomerular volume (0.0025, 0.0031, and 0.0028 µ m 3 , respectively) and in glomerulosclerosis (18%, 7%, and 11%, respectively). There was a marked increase in glomerulosclerosis with age in the superficial region, but larger glomerular volume was not associated with age at any cortical depth. Glomerulosclerosis associated more strongly with arteriosclerosis and ischemic-appearing glomeruli in the superficial region. Hypertension, lower eGFR, and interstitial fibrosis associated with glomerulosclerosis and glomerular volume to a similar extent at any depth. Diabetes and proteinuria more strongly associated with glomerulosclerosis in the deep and middle regions, respectively, but neither associated with glomerular volume differently by depth. Obesity associated more strongly with glomerular volume in the superficial cortex. Conclusions Most clinical characteristic show similar associations with glomerulosclerosis and glomerulomegaly at different cortical depths. Exceptions include age-related glomerulosclerosis, which appears to be an ischemic process and is more predominant in the superficial region.
Recognizing Risk Factors Associated With Unplanned 30-Day Readmissions in Hematopoietic Cell Transplantation
Kharfan‐Dabaja, Mohamed A. , Alvarnas, Joseph

Mayo Clinic

JAMA Network Open | July 5, 2019 | Volume: 2 | Issue: 7 | Pages: e196463

10.1001/jamanetworkopen.2019.6463 | PMID 31276171 Get It

Incidence and Impact of Acute Kidney Injury in Patients Receiving Extracorporeal Membrane Oxygenation: A Meta-Analysis
Cheungpasitporn, Wisit , Lertjitbanjong, Ploypin , Aeddula, Narothama Reddy , Watthanasuntorn, Kanramon , Srivali, Narat , Mao, Michael A. , Cheungpasitporn, Wisit , Aeddula, Narothama Reddy , Mao, Michael A , Srivali, Narat , Thongprayoon, Charat , Kashani, Kianoush

Mayo Clinic

Journal of Clinical Medicine | July 5, 2019 | Volume: 8 | Issue: 7 | Pages: 981

10.3390/jcm8070981 | PMID 31284451 Get It

Background: Although acute kidney injury (AKI) is a frequent complication in patients receiving extracorporeal membrane oxygenation (ECMO), the incidence and impact of AKI on mortality among patients on ECMO remain unclear. We conducted this systematic review to summarize the incidence and impact of AKI on mortality risk among adult patients on ECMO. Methods: A literature search was performed using EMBASE, Ovid MEDLINE, and Cochrane Databases from inception until March 2019 to identify studies assessing the incidence of AKI (using a standard AKI definition), severe AKI requiring renal replacement therapy (RRT), and the impact of AKI among adult patients on ECMO. Effect estimates from the individual studies were obtained and combined utilizing random-effects, generic inverse variance method of DerSimonian-Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42018103527). Results: 41 cohort studies with a total of 10,282 adult patients receiving ECMO were enrolled. Overall, the pooled estimated incidence of AKI and severe AKI requiring RRT were 62.8% (95%CI: 52.1%–72.4%) and 44.9% (95%CI: 40.8%–49.0%), respectively. Meta-regression showed that the year of study did not significantly affect the incidence of AKI (p = 0.67) or AKI requiring RRT (p = 0.83). The pooled odds ratio (OR) of hospital mortality among patients receiving ECMO with AKI on RRT was 3.73 (95% CI, 2.87–4.85). When the analysis was limited to studies with confounder-adjusted analysis, increased hospital mortality remained significant among patients receiving ECMO with AKI requiring RRT with pooled OR of 3.32 (95% CI, 2.21–4.99). There was no publication bias as evaluated by the funnel plot and Egger’s regression asymmetry test with p = 0.62 and p = 0.17 for the incidence of AKI and severe AKI requiring RRT, respectively. Conclusion: Among patients receiving ECMO, the incidence rates of AKI and severe AKI requiring RRT are high, which has not changed over time. Patients who develop AKI requiring RRT while on ECMO carry 3.7-fold higher hospital mortality.
Brain Lewy-Type Synucleinopathy Density Is Associated with a Lower Prevalence of Atherosclerotic Cardiovascular Disease Risk Factors in Patients with Parkinson’s Disease
Driver‐Dunckley, Erika , Sue, Lucia I., Shill, Holly A. , Mehta, Shyamal H. , Belden, Christine M. , Zamrini, Edward , Davis, Kathryn, Beach, Thomas G. , Driver-Dunckley, Erika D., Zhang, Nan , Adler, Charles H. , Serrano, Geidy E.

Mayo Clinic

Journal of Parkinson’s Disease | July 5, 2019 | Volume: 9 | Issue: 3 | Pages: 543-552

10.3233/jpd-191610 | PMID 31282425 Get It

Background: Some epidemiology studies suggest that atherosclerotic cardiovascular disease (ASCVD) risk factors increase the risk of developing Parkinson’s disease (PD). However, conflicting data suggest lower rates of ASCVD in PD. Objective: The objective of this study is to determine, with data from a longitudinal clinicopathological study, whether ASCVD risk factors are associated with a PD diagnosis and/or increased brain or peripheral load of Lewy-type synucleinopathy (LTS). Methods: All subjects were followed to autopsy and neuropathological examination in the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND). Multivariable regression models, including age, gender, and smoking history, were used to investigate the association of a PD diagnosis or brain or submandibular gland LTS load with ASCVD risk factors. Results: 150 subjects were included (PD n = 60, controls n = 90). Univariable comparisons and regression models showed a general trend to inverse associations. The multivariable odds ratio (OR) of brain LTS load for carotid artery disease was 0.93 (95% CI: 0.86 to 0.98; p = 0.02), for anticoagulant use 0.95 (95% CI: 0.90 to 0.99; p = 0.04) and for abnormal heart weight 0.96 (95% CI: 0.92 to 0.99; p = 0.01). Composite clinical and overall (clinical + pathology composite risk scores) composite risk scores were also significantly lower in the PD subjects ( p = 0.0164 and 0.0187, respectively). Submandibular gland LTS load was not significantly related to ASCVD conditions. Conclusions: This study shows associations of higher brain LTS with lower prevalence of both clinical and pathological indices of ASCVD in PD subjects versus age-similar controls. We suggest that this is due to α-synuclein pathology-induced sympathetic denervation in PD.
Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis
Saleh, Abdullah S. Al , Sidiqi, M Hasib , Sidana, Surbhi , Muchtar, Eli , Dingli, David , Lacy, Martha Q. , Warsame, Rahma , Gonsalves, Wilson I. , Kourelis, Taxiarchis , Hayman, Suzanne R. , Kapoor, Prashant , Kumar, Shaji , Al Saleh, Abdullah S , Dispenzieri, Angela , Warsame, Rahma , Gonsalves, Wilson , Kourelis, Taxiarchis , Wolf, Robert C, Gertz, Morie A , Muchtar, E , Sidiqi, M Hasib , Sidana, Surbhi , Dingli, David , Dispenzieri, Angela , Hogan, William J. , Wolf, Robert Christian , Buadi, Francis K. , Gertz, Morie A.

Mayo Clinic

American Journal of Hematology | July 5, 2019 | Volume: 94 | Issue: 10 | Pages: 1066-1071

10.1002/ajh.25572 | PMID 31273808 Get It

AbstractThe role of consolidation post autologous stem cell transplant in light chain amyloidosis is not well defined. We retrospectively identified patients who had light chain amyloidosis and underwent autologous stem cell transplant at the Mayo Clinic. Consolidation was defined as any treatment given after the day 100 evaluation post‐transplant to maintain or deepen the response. We identified 471 patients, of whom 72 (15%) received consolidation. Patients receiving consolidation had more advanced disease (Mayo 2012 stage ≥II in 67% vs 52%, P = .02), and had lower day 100 response rates (very good partial response or better: 35% vs 84%, P < .001). After consolidation, rates of very good partial response improved from 24% to 28%, and rates of complete response improved from 11% to 40%. Patients with less than very good partial response who received consolidation, had better progression‐free survival (median of 22.4 vs 8.8 months, P < .001), and the benefit was greater in those who deepened their response (median of 41 vs 8.8 months, P < .001). In patients with less than very good partial response, there was a trend for better overall survival in patients who responded to consolidation (median of 125.8 vs 74.4 months, P = .07). In patients who achieved very good partial response, or better, at day 100 post autologous stem cell transplant, consolidation did not improve progression‐free or overall survival. Consolidation after autologous stem cell transplant for light chain amyloidosis improves progression‐free survival for patients who achieve less than very good partial response.
Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer
Annels, Nicola , Arif, Mehreen, Ballesteros‐Merino, Carmen , Simpson, Guy R. , Denyer, Mick, Sandhu, Sarbjinder, Melcher, Alan , Harrington, Kevin J. , Davies, B., Au, Gough G. , Grose, Mark, Bagwan, Izhar , Fox, Bernard A. , Vile, Richard G. , Mostafid, Hugh , Shafren, Darren R., Pandha, Hardev , Ballesteros-Merino, Carmen , Melcher, Alan A , Harrington, Kevin , Mansfield, David

Mayo Clinic

Clinical Cancer Research | July 5, 2019 | Volume: 25 | Issue: 19 | Pages: 5818-5831

10.1158/1078-0432.ccr-18-4022 | PMID 31273010 Get It

Abstract Purpose: The CANON [CAVATAK in NON–muscle-invasive bladder cancer (NMIBC)] study evaluated a novel ICAM-1–targeted immunotherapeutic-coxsackievirus A21 as a novel oncolytic agent against bladder cancer. Patients and Methods: Fifteen patients enrolled in this “window of opportunity” phase I study, exposing primary bladder cancers to CAVATAK prior to surgery. The first 9 patients received intravesical administration of monotherapy CAVATAK; in the second stage, 6 patients received CAVATAK with a subtherapeutic dose of mitomycin C, known to enhance expression of ICAM-1 on bladder cancer cells. The primary endpoint was to determine patient safety and maximum tolerated dose (MTD). Secondary endpoints were evidence of viral replication, induction of inflammatory cytokines, antitumor activity, and viral-induced changes in resected tissue. Results: Clinical activity of CAVATAK was demonstrated by induction of tumor inflammation and hemorrhage following either single or multiple administrations of CAVATAK in multiple patients, and a complete resolution of tumor in 1 patient. Whether used alone or in combination with mitomycin C, CAVATAK caused marked inflammatory changes within NMIBC tissue biopsies by upregulating IFN-inducible genes, including both immune checkpoint inhibitory genes (PD-L1 and LAG3) and Th1-associated chemokines, as well as the induction of the innate activator RIG-I, compared with bladder cancer tissue from untreated patients. No significant toxicities were reported in any patient, from either virus or combination therapy. Conclusions: The acceptable safety profile of CAVATAK, proof of viral targeting, replication, and tumor cell death together with the virus-mediated increases in “immunological heat” within the tumor microenvironment all indicate that CAVATAK may be potentially considered as a novel therapeutic for NMIBC.
Open Shoulder Stabilization for Instability: Anterior Labral Repair With Capsular Shift
Strother, Courtney R. Carlson, McLaughlin, Richard J. , Krych, Aaron J. , Carlson Strother, Courtney R, Sanchez-Sotelo, Joaquin, Krych, Aaron J , Sánchez‐Sotelo, Joaquín , Camp, Christopher L.

Mayo Clinic

Arthroscopy Techniques | July 4, 2019 | Volume: 8 | Issue: 7 | Pages: No page available

10.1016/j.eats.2019.03.011 | PMID 31485402 Get It

Abstract Although anterior shoulder instability is most commonly treated with arthroscopic fixation, open labral repair with capsular shift may be best for select patients and in cases of revision stabilization without significant bone loss. The technique described in this article uses the deltopectoral interval; it involves careful dissection of the subscapularis from the anterior capsule, repair of the Bankart lesion, and a lateral and superior capsular shift using all‐suture anchors in the humeral head. Advantages of this technique include meticulous control of anchor placement and the ability to provide additional stability via a lateral and superiorly directed capsular shift. This operation can be performed in a reliable, efficient, and reproducible manner. Technique Video video See video under supplementary data.